DNB Asset Management AS decreased its position in shares of DaVita Inc. (NYSE:DVA – Free Report) by 1.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 43,007 shares of the company’s stock after selling 724 shares during the period. DNB Asset Management AS’s holdings in DaVita were worth $4,321,000 at the end of the most recent quarter.
Other hedge funds have also recently bought and sold shares of the company. Parkside Financial Bank & Trust raised its position in DaVita by 88.6% in the 1st quarter. Parkside Financial Bank & Trust now owns 313 shares of the company’s stock valued at $35,000 after purchasing an additional 147 shares in the last quarter. Bessemer Group Inc. raised its position in DaVita by 55.1% in the 1st quarter. Bessemer Group Inc. now owns 445 shares of the company’s stock valued at $36,000 after purchasing an additional 158 shares in the last quarter. Mirova acquired a new stake in DaVita in the 1st quarter valued at about $42,000. AlphaMark Advisors LLC raised its position in DaVita by 66.0% in the 1st quarter. AlphaMark Advisors LLC now owns 528 shares of the company’s stock valued at $43,000 after purchasing an additional 210 shares in the last quarter. Finally, CWM LLC raised its position in DaVita by 78.1% in the 1st quarter. CWM LLC now owns 830 shares of the company’s stock valued at $67,000 after purchasing an additional 364 shares in the last quarter. Institutional investors and hedge funds own 84.69% of the company’s stock.
Insider Buying and Selling
In related news, insider Kathleen Alyce Waters sold 9,794 shares of the firm’s stock in a transaction that occurred on Tuesday, August 22nd. The stock was sold at an average price of $101.81, for a total transaction of $997,127.14. Following the transaction, the insider now owns 81,297 shares in the company, valued at approximately $8,276,847.57. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.40% of the stock is currently owned by company insiders.
Wall Street Analysts Forecast Growth
View Our Latest Research Report on DVA
DaVita Price Performance
Shares of NYSE DVA opened at $98.71 on Monday. The company has a debt-to-equity ratio of 7.13, a quick ratio of 1.20 and a current ratio of 1.25. DaVita Inc. has a fifty-two week low of $65.28 and a fifty-two week high of $116.97. The firm has a market capitalization of $9.01 billion, a PE ratio of 19.62, a price-to-earnings-growth ratio of 1.08 and a beta of 0.94. The stock’s 50-day simple moving average is $102.44 and its 200-day simple moving average is $94.97.
DaVita (NYSE:DVA – Get Free Report) last released its quarterly earnings results on Thursday, August 3rd. The company reported $2.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.66 by $0.42. The firm had revenue of $3 billion for the quarter, compared to the consensus estimate of $2.95 billion. DaVita had a return on equity of 60.67% and a net margin of 3.98%. The firm’s quarterly revenue was up 2.5% compared to the same quarter last year. During the same quarter last year, the business posted $2.30 EPS. As a group, equities research analysts forecast that DaVita Inc. will post 7.23 EPS for the current fiscal year.
About DaVita
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Recommended Stories
- Five stocks we like better than DaVita
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 3 Reasons This Sleeping Giant Is About To Wake Up
- Stock Market Upgrades: What Are They?
- MarketBeat Week in Review – 9/18 – 9/22
- What Are Dividend Challengers?
- 52-week Low Names To Tip The Upside Scale In Your Favor
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA – Free Report).
Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.
